Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
A technology for diseases, alkylation, applied in the field of medicine
Inactive Publication Date: 2011-09-14
KALYPSYS INC +1
View PDF2 Cites 7 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Finally, among other side effects, H 1 Sedation by R antagonists limits many H
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0302]
[0303] 4-(4-(3,4-dichlorophenyl)piperazin-1-yl)-5-methylthieno[2,3-d]pyrimidine
[0304] The title compound was obtained commercially.
Embodiment 2
[0306]
[0307] 5-methyl-4-(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)thieno[2,3-d]pyrimidine
[0308] The title compound was obtained commercially.
Embodiment 3
[0310]
[0311] 4-(4-(2-Chlorophenyl)piperazin-1-yl)-5-methylthieno[2,3-d]pyrimidine
[0312] The title compound was obtained commercially.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The present invention relates to compounds and methods which may be useful as inhibitors of HiR and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
Description
[0001] This application claims the benefit of priority from US Provisional Patent Application Serial No. 61 / 095,819, filed September 10, 2008, the disclosure of which is hereby incorporated by reference as if incorporated herein in its entirety. technical field [0002] Disclosed herein are novel heterocyclic compounds and compositions, and their use as medicaments for the treatment of disease. Also provided are methods of inhibiting the activity of histamine receptors in a human or animal subject for the treatment of allergic disease, inflammation, asthma, rhinitis, chronic obstructive pulmonary disease, conjunctivitis, rheumatoid arthritis, and generalized and localized pruritus disease. Background technique [0003] Histamine, a low molecular weight biogenic amine, is a potent chemical modulator of normal and pathophysiology. Histamine functions as a secreted signal and neurotransmitter of immune and inflammatory responses. Through four different cell surface receptors ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more IPC IPC(8): A61K31/519A61P29/00A61P37/08A61P27/02
CPCA61K9/0048A61K31/519A61K9/0043A61K31/4365A61K9/0073C07D495/04A61K31/5377A61K31/497A61K45/06A61P1/00A61P11/02A61P11/06A61P17/00A61P17/04A61P19/02A61P25/04A61P27/02A61P29/00A61P29/02A61P37/00A61P37/06A61P37/08A61P43/00A61K2300/00
Inventor A·J·博尔夏特C·博勒加德R·L·戴维斯D·A·加马什J·M·扬尼
Owner KALYPSYS INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap